Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Calcitonin Receptor Plays a Major Role in Glucose Regulation as a Function of Dual Amylin and Calcitonin Receptor Agonist Therapy
Anna Thorsø Larsen, Nina Sonne, Kim Vietz Andreassen, et al.
Journal of Pharmacology and Experimental Therapeutics (2020) Vol. 374, Iss. 1, pp. 74-83
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

GPCR drug discovery: new agents, targets and indications
José A. Lorente, Aleksandr V. Sokolov, Gavin Ferguson, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 4
Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat
David S. Mathiesen, Asger Lund, Tina Vilsbøll, et al.
Frontiers in Endocrinology (2021) Vol. 11
Open Access | Times Cited: 56
A structural basis for amylin receptor phenotype
Jianjun Cao, Matthew J. Belousoff, Yi-Lynn Liang, et al.
Science (2022) Vol. 375, Iss. 6587
Closed Access | Times Cited: 48
Mediators of Amylin Action in Metabolic Control
Christina N. Boyle, Yi Zheng, Thomas A. Lutz
Journal of Clinical Medicine (2022) Vol. 11, Iss. 8, pp. 2207-2207
Open Access | Times Cited: 33
AM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists
Madeleine M. Fletcher, Peter Keov, Tin T. Truong, et al.
Journal of Pharmacology and Experimental Therapeutics (2021) Vol. 377, Iss. 3, pp. 417-440
Open Access | Times Cited: 40
Development of a Novel Assay for Direct Assessment of Selective Amylin Receptor Activation Reveals Novel Differences in Behavior of Selective and Nonselective Peptide Agonists
Peter Keov, George Christopoulos, Caroline A. Hick, et al.
Molecular Pharmacology (2024) Vol. 105, Iss. 5, pp. 359-373
Open Access | Times Cited: 5
Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases
Nina Sonne, M.A. Karsdal, Kim Henriksen
Molecular Metabolism (2020) Vol. 46, pp. 101109-101109
Open Access | Times Cited: 39
The protective effect of amylin in type 2 diabetes: Yes or no
Mohammad Saud Alanazi, Hayder M. Al‐kuraishy, Ali K. Albuhadily, et al.
European Journal of Pharmacology (2025), pp. 177593-177593
Open Access
Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors
Jianjun Cao, Matthew J. Belousoff, Rachel M. Johnson, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
The Goldilocks for chronic weight management—Balancing quantity with quality of weight loss
Kim Henriksen, Manu V. Chakravarthy, Cecilie Liv Bager, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long‐acting dual amylin and calcitonin receptor agonist improves insulin‐mediated glycaemic control and controls body weight
Simone Anna Melander, Anna Thorsø Larsen, M.A. Karsdal, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 12, pp. 1829-1842
Closed Access | Times Cited: 3
KBP-066A, a long-acting dual amylin and calcitonin receptor agonist, induces weight loss and improves glycemic control in obese and diabetic rats
Kim Vietz Andreassen, Anna Thorsø Larsen, Nina Sonne, et al.
Molecular Metabolism (2021) Vol. 53, pp. 101282-101282
Open Access | Times Cited: 23
Does receptor balance matter? – Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models
Anna Thorsø Larsen, Khaled Elhady Mohamed, Nina Sonne, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113842-113842
Open Access | Times Cited: 16
The roles of hepatokine and osteokine in liver-bone crosstalk: Advance in basic and clinical aspects
Zhanghao Li, Xiaoxin Wen, Nanxi Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
Dual amylin and calcitonin receptor agonist treatment improves insulin sensitivity and increases muscle-specific glucose uptake independent of weight loss
Anna Thorsø Larsen, Simone Anna Melander, Nina Sonne, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114969-114969
Open Access | Times Cited: 7
Treatment sequencing using the dual amylin and calcitonin receptor agonist KBP-336 and semaglutide results in durable weight loss
Anna Thorsø Larsen, M.A. Karsdal, Kim Henriksen
European Journal of Pharmacology (2023) Vol. 954, pp. 175837-175837
Closed Access | Times Cited: 7
DACRA induces profound weight loss, satiety control, and increased mitochondrial respiratory capacity in adipose tissue
E. A. Petersen, Ida Blom, Simone Anna Melander, et al.
International Journal of Obesity (2024)
Closed Access | Times Cited: 2
Novel Pharmaceuticals in Appetite Regulation: Exploring emerging gut peptides and their pharmacological prospects
Igor Rubinić, Marija Kurtov, Robert Likić
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 2
THERAPY OF ENDOCRINE DISEASE: Amylin and calcitonin – physiology and pharmacology
David S. Mathiesen, Asger Lund, Jens J. Holst, et al.
European Journal of Endocrinology (2022) Vol. 186, Iss. 6, pp. R93-R111
Open Access | Times Cited: 11
Structural insight into selectivity of amylin and calcitonin receptor agonists
Jianjun Cao, Matthew J. Belousoff, Elliot Gerrard, et al.
Nature Chemical Biology (2023) Vol. 20, Iss. 2, pp. 162-169
Open Access | Times Cited: 6
The Impact of Exposure Profile on the Efficacy of Dual Amylin and Calcitonin Receptor Agonist Therapy
Nina Sonne, Anna Thorsø Larsen, M.A. Karsdal, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2365-2365
Open Access | Times Cited: 8
Poly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin C
Manuela Giansanti, Antonio De Gabrieli, Salvatore Pasquale Prete, et al.
Journal of Pharmacology and Experimental Therapeutics (2021) Vol. 377, Iss. 3, pp. 385-397
Open Access | Times Cited: 9
Development of High Affinity Calcitonin Analog Fragments Targeting Extracellular Domains of Calcitonin Family Receptors
Sang Min Lee
Biomolecules (2021) Vol. 11, Iss. 9, pp. 1364-1364
Open Access | Times Cited: 8
Modulation of amylin and calcitonin receptor activation by hybrid peptides
Sang Min Lee
Peptides (2024), pp. 171314-171314
Closed Access
PECULIARITIES OF THE EFFECT OF AMYLINE ON THE INTENSITY OF INFLAMMATORY PROCESSES CAUSED BY THERMAL AND CHEMICAL BURNS
H. V. Lukyantseva, В. А. Пастухова, S. P. Krasnova, et al.
Bulletin of Problems Biology and Medicine (2021) Vol. 2, Iss. 1, pp. 71-71
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top